ADAPTIN BIO, INC. 10-Q filing
Filed 2026-05-15 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001213900-26-057188
- Form type
- 10-Q
- CIK
- 0001938571
- Primary document
- https://www.sec.gov/Archives/edgar/data/1938571/000121390026057188/ea0289315-10q_adaptin.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ADAPTIN BIO, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-1.1M | - | - |
| Net Income | $-1.1M | - | - |
| Eps Basic | -0.13 | - | - |
| Eps Diluted | 0.13 | - | - |
| Cash And Equivalents | $301,309 | - | - |
| Total Assets | $706,117 | - | - |
| Total Liabilities | $2.5M | - | - |
| Shareholders Equity | $-1.8M | - | - |
| Operating Cash Flow | $-596,298 | - | - |